TABLE 1.
Bacterial strains used in this study
| Strain | Relevant featuresa | Reference or source |
|---|---|---|
| B. mallei ATCC 23344 | Human clinical isolate; Kms Pbr | 26 |
| B. mallei CSM001 | B. mallei ATCC 23344 with mini-Tn5::luxKm2; Kmr Pbr | 27 |
| B. mallei TMM001 | B. mallei ATCC 23344 with an unmarked intragenic deletion in bmaa1801 (ΔtonB) | 16 |
| B. mallei CLH001 | B. mallei TMM001 with unmarked intragenic deletion in bmaa0742 (Δhcp1) | This study |
| B. mallei CLH002 | B. mallei ATCC 23344 with an unmarked intragenic deletion of bmaa0742 (Δhcp1) | This study |
| E. coli S17-1 (pMo130-ΔBPSS1498) | Donor strain containing pMo130–Δbpss1498 plasmid; Smr Tpr Pbs Kmr | 22 |
a
Km, kanamycin; Pb, polymyxin B; Sm, streptomycin; Tp, trimethoprim.